These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 28329292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M, Dokainish H, Lakkis NM.
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D, Finocchiaro G, Tibayan Y, Chi J, Pavlovic A, Kim YM, Tibayan FA, Reitz BA, Robbins RC, Woo J, Ha R, Lee DP, Ashley EA.
    J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
    Fortunato de Cano S, Nicolas Cano M, de Ribamar Costa J, Alves Pinheiro J, Bellio de Mattos Barretto R, Costa de Souza Le Bihan D, Abizaid A, Sousa A, Eduardo Sousa J.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):953-960. PubMed ID: 27143093
    [Abstract] [Full Text] [Related]

  • 5. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Singh K, Qutub M, Carson K, Hibbert B, Glover C.
    Catheter Cardiovasc Interv; 2016 Jul 15; 88(1):107-15. PubMed ID: 26526299
    [Abstract] [Full Text] [Related]

  • 6. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
    Zhu C, Tang B, Cui H, Wang S, Xiao M, Chen Z, Meng Y, Zhao S, Song Y, Yu Q, Wang S.
    J Card Surg; 2019 Jul 15; 34(7):533-540. PubMed ID: 31111576
    [Abstract] [Full Text] [Related]

  • 7. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S, Fiarresga A, Galrinho A, Cacela D, Ramos R, de Sousa L, Gonçalves A, Bernardes L, Patrício L, Branco LM, Ferreira RC.
    Rev Port Cardiol (Engl Ed); 2019 Jul 15; 38(7):473-480. PubMed ID: 31495717
    [Abstract] [Full Text] [Related]

  • 8. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
    Liebregts M, Vriesendorp PA, Mahmoodi BK, Schinkel AF, Michels M, ten Berg JM.
    JACC Heart Fail; 2015 Nov 15; 3(11):896-905. PubMed ID: 26454847
    [Abstract] [Full Text] [Related]

  • 9. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M, Dokainish H, Lakkis N.
    J Interv Cardiol; 2006 Aug 15; 19(4):319-27. PubMed ID: 16881978
    [Abstract] [Full Text] [Related]

  • 10. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
    Balt JC, Wijffels MC, Boersma LV, Wever EF, ten Berg JM.
    Heart; 2014 Dec 15; 100(23):1865-70. PubMed ID: 25073885
    [Abstract] [Full Text] [Related]

  • 11. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Yokoyama Y, Shimoda T, Shimada YJ, Shimamura J, Akita K, Yasuda R, Takayama H, Kuno T.
    Eur J Cardiothorac Surg; 2023 Mar 01; 63(3):. PubMed ID: 36782361
    [Abstract] [Full Text] [Related]

  • 12. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
    Osman M, Kheiri B, Osman K, Barbarawi M, Alhamoud H, Alqahtani F, Alkhouli M.
    Clin Cardiol; 2019 Jan 01; 42(1):190-197. PubMed ID: 30421437
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years.
    Lemor A, Villablanca PA, Hosseini Dehkordi SH, Mand R, Hernandez GA, Jain T, Blumer VL, Lee J, Eng M, Guerrero M, Wang DD, Palacios I, O'Neill W.
    Am J Cardiol; 2020 Jul 15; 127():128-134. PubMed ID: 32402483
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
    Liebregts M, Steggerda RC, Vriesendorp PA, van Velzen H, Schinkel AF, Willems R, van Cleemput J, van den Berg MP, Michels M, ten Berg JM.
    JACC Cardiovasc Interv; 2016 Mar 14; 9(5):463-9. PubMed ID: 26965935
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
    Yao L, Li L, Lu XJ, Miao YL, Kang XN, Duan FJ.
    Cardiovasc Ultrasound; 2016 May 17; 14(1):18. PubMed ID: 27189485
    [Abstract] [Full Text] [Related]

  • 18. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Vermaete I, Dujardin K, Stammen F.
    Acta Cardiol; 2020 Oct 17; 75(6):483-491. PubMed ID: 31204591
    [Abstract] [Full Text] [Related]

  • 19. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
    Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ.
    Circ Cardiovasc Interv; 2019 Jul 17; 12(7):e007673. PubMed ID: 31296080
    [Abstract] [Full Text] [Related]

  • 20. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC, Damman K, Balt JC, Liebregts M, ten Berg JM, van den Berg MP.
    JACC Cardiovasc Interv; 2014 Nov 17; 7(11):1227-34. PubMed ID: 25326737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.